Dr. Curtiland Deville

Associate Professor in the Department of Radiation Oncology and Molecular Radiation Sciences at Johns Hopkins University School of Medicine

Dr. Deville is a distinguished Associate Professor in the Department of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins University School of Medicine. He holds the roles of Medical Director at the Johns Hopkins Proton Therapy Center and Clinical Director and Chair of Sibley Radiation Oncology. Dr. Deville is renowned for his clinical expertise in treating patients with prostate cancer and soft tissue sarcoma, utilizing advanced radiation techniques such as proton therapy to improve tumor targeting and minimize toxicity.

His research, which focuses on enhancing radiation therapy precision and safety, is well-supported and has led to over 170 peer-reviewed publications. Dr. Deville also serves as a Deputy Editor for the International Journal of Radiation Oncology, Biology, and Physics, contributing significantly to the field through his scholarly work.

Beyond his clinical and research endeavors, Dr. Deville is a proactive advocate for Health Equity, Diversity, and Inclusion (HEDI) within radiation oncology. He was instrumental in establishing the American Society for Radiation Oncology's (ASTRO) Council on HEDI and has recently been elected to the ASTRO Board of Directors, underscoring his leadership and commitment to advancing the field. Dr. Deville's contributions continue to influence the practice of radiation oncology, making him a respected voice in his profession and a vital agent for change in cancer care.